COMSATS and Syndesis Health Inc. move to collaborate in Genomic Sequencing Programs
NEW YORK, April 4, 2023 (Newswire.com) - The Commission on Science and Technology for Sustainable Development in the South (COMSATS), an intergovernmental organization of 27 Member States, signed a Letter of Intent (LoI) with the Syndesis Health Inc. The LOI would enable reaching a Memorandum of Understanding for cooperation in "National Genomic Sequencing Programs" for the COMSATS Member States.
Syndesis Health Inc. is a company incorporated in Delaware, USA, with its business office in New York. It accelerates research and innovation for healthcare, life sciences, and biotechnology companies.
The LOI was signed by the COMSATS Executive Director Amb. Dr. Mohammad Nafees Zakaria and Syndesis Health Inc.'s Co-Founder and Director, Mr. Kamil Mehmood.
This collaboration will enable better healthcare, promote R&D, acquire scientific knowledge, technical and technological knowhow, for the COMSATS Member Countries' Scientific community and citizens, and empower healthcare organisations. The cooperation will devise technical programs for upscaling healthcare infrastructure in COMSATS Member States and provide AI-powered software and analytics.
About Syndesis
Syndesis Health accelerates research and innovation for healthcare, life sciences, and biotechnology companies. The Syndesis Health Network enables secure collaboration amongst member organizations and is empowered by the Syndesis Data Platform which provides secure access to a multi-country, real-world data set. The data is comprised of millions of longitudinal, anonymized records, representing complete journeys for a diverse population of patients across many common and rare diseases. Visit our website at https://syndesis.com to learn more.
Leah Patterson
Chief Marketing Officer
[email protected]
+1.646.274.1420
Original Source: COMSATS and Syndesis Health Inc. Move to Collaborate in Genomic Sequencing Programs
